129 related articles for article (PubMed ID: 34512985)
41. Therapy-related core binding factor acute myeloid leukemia.
George B; Yohannan B; Mohlere V; Gonzalez A
Int J Hematol Oncol; 2023 Feb; 12(1):IJH43. PubMed ID: 36874378
[TBL] [Abstract][Full Text] [Related]
42. The PEBP2betaMYH11 fusion created by Inv(16)(p13;q22) in myeloid leukemia impairs neutrophil maturation and contributes to granulocytic dysplasia.
Kogan SC; Lagasse E; Atwater S; Bae SC; Weissman I; Ito Y; Bishop JM
Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11863-8. PubMed ID: 9751756
[TBL] [Abstract][Full Text] [Related]
43. Comparative analysis of genes regulated in acute myelomonocytic leukemia with and without inv(16)(p13q22) using microarray techniques, real-time PCR, immunohistochemistry, and flow cytometry immunophenotyping.
Sun X; Zhang W; Ramdas L; Stivers DN; Jones DM; Kantarjian HM; Estey EH; Vadhan-Raj S; Medeiros LJ; Bueso-Ramos CE
Mod Pathol; 2007 Aug; 20(8):811-20. PubMed ID: 17571080
[TBL] [Abstract][Full Text] [Related]
44. Deletion of CBFB in a patient with acute myelomonocytic leukemia (AML M4Eo) and inversion 16.
Egan N; O'Reilly J; Chipper L; Higgins M; Herrmann R; Cannell P
Cancer Genet Cytogenet; 2004 Oct; 154(1):60-2. PubMed ID: 15381374
[TBL] [Abstract][Full Text] [Related]
45. Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG).
Paschka P; Du J; Schlenk RF; Gaidzik VI; Bullinger L; Corbacioglu A; Späth D; Kayser S; Schlegelberger B; Krauter J; Ganser A; Köhne CH; Held G; von Lilienfeld-Toal M; Kirchen H; Rummel M; Götze K; Horst HA; Ringhoffer M; Lübbert M; Wattad M; Salih HR; Kündgen A; Döhner H; Döhner K
Blood; 2013 Jan; 121(1):170-7. PubMed ID: 23115274
[TBL] [Abstract][Full Text] [Related]
46. [Case Conference of Hematological Malignancies Based on the Morphology of Blood Cells: Chairmen's Introductory Remarks].
Inaba T; Ikemoto T
Rinsho Byori; 2016 Nov; 64(11):1310-1312. PubMed ID: 30695313
[TBL] [Abstract][Full Text] [Related]
47. Systemic mastocytosis is uncommon in KIT D816V mutation positive core-binding factor acute myeloid leukemia.
Kristensen T; Preiss B; Broesby-Olsen S; Vestergaard H; Friis L; Møller MB
Leuk Lymphoma; 2012 Jul; 53(7):1338-44. PubMed ID: 22145956
[TBL] [Abstract][Full Text] [Related]
48. Molecular Cytogenetic Characterization of a Structural Abnormal Chromosome 16 in a Patient with Acute Myeloid Leukemia Leading to Inversion Chromosome 16 with Concomitant 3'CBFB Deletion.
Hurtado R; Guirales F; Wang A; Hamid B; Okabe A; Castro E; Tirado CA
J Assoc Genet Technol; 2022; 48(1):17-23. PubMed ID: 35247255
[TBL] [Abstract][Full Text] [Related]
49. Characteristics of translocation (16;16)(p13;q22) acute myeloid leukemia.
Eghtedar A; Borthakur G; Ravandi F; Jabbour E; Cortes J; Pierce S; Kantarjian H; Garcia-Manero G
Am J Hematol; 2012 Mar; 87(3):317-8. PubMed ID: 22228403
[TBL] [Abstract][Full Text] [Related]
50. Detection and quantification of CBFB/MYH11 fusion transcripts in patients with inv(16)-positive acute myeloblastic leukemia by real-time RT-PCR.
Krauter J; Hoellge W; Wattjes MP; Nagel S; Heidenreich O; Bunjes D; Ganser A; Heil G
Genes Chromosomes Cancer; 2001 Apr; 30(4):342-8. PubMed ID: 11241787
[TBL] [Abstract][Full Text] [Related]
51. inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations.
Schwind S; Edwards CG; Nicolet D; Mrózek K; Maharry K; Wu YZ; Paschka P; Eisfeld AK; Hoellerbauer P; Becker H; Metzeler KH; Curfman J; Kohlschmidt J; Prior TW; Kolitz JE; Blum W; Pettenati MJ; Dal Cin P; Carroll AJ; Caligiuri MA; Larson RA; Volinia S; Marcucci G; Bloomfield CD;
Blood; 2013 Jan; 121(2):385-91. PubMed ID: 23160462
[TBL] [Abstract][Full Text] [Related]
52. Identification of a novel CBFB-MYH11 transcript: implications for RT-PCR diagnosis.
Van der Reijden BA; de Wit L; van der Poel S; Luiten EB; Lafage-Pochitaloff M; Dastugue N; Gabert J; Löwenberg B; Jansen JH
Hematol J; 2001; 2(3):206-9. PubMed ID: 11920247
[TBL] [Abstract][Full Text] [Related]
53. Bundles of Auer rods in mature neutrophils in an acute myeloid leukaemia patient with inv(16)(p13.1q22) CBFB-MYH 11.
Rakotoarivelo ZH; Lefebvre T; Lamarque M; Harzallah I; Debliquis A
Br J Haematol; 2023 Feb; 200(4):398. PubMed ID: 36441114
[No Abstract] [Full Text] [Related]
54. [A case of del(16)(q22) in a patient with acute myeloid leukemia with complex karyotype].
Kim M; Lee JW; Lee JK; Hong YJ; Hong SI; Kang HJ; Cho EH; Chang YH
Korean J Lab Med; 2010 Aug; 30(4):329-33. PubMed ID: 20805702
[TBL] [Abstract][Full Text] [Related]
55. Molecular analysis of minimally differentiated acute myeloid leukemia with chromosome 16 inversion.
Sotomatsu M; Ogawa C; Shimoda M; Matsui A; Nakazawa S; Eguchi M; Morikawa A
Leuk Lymphoma; 1997 Jan; 24(3-4):319-25. PubMed ID: 9156661
[TBL] [Abstract][Full Text] [Related]
56. Acute myeloid leukemia with t(10;17)(p13;q12) chromosome translocation: a case report and literature review.
Li L; Zhou F; Hou J
Am J Blood Res; 2012; 2(4):265-8. PubMed ID: 23226626
[TBL] [Abstract][Full Text] [Related]
57. Myeloid Sarcoma With CBFB-MYH11 Fusion (inv(16) or t(16;16)) Prevails in the Abdomen.
Dalland JC; Meyer R; Ketterling RP; Reichard KK
Am J Clin Pathol; 2020 Feb; 153(3):333-341. PubMed ID: 31671434
[TBL] [Abstract][Full Text] [Related]
58. Role of Cbfb in hematopoiesis and perturbations resulting from expression of the leukemogenic fusion gene Cbfb-MYH11.
Kundu M; Chen A; Anderson S; Kirby M; Xu L; Castilla LH; Bodine D; Liu PP
Blood; 2002 Oct; 100(7):2449-56. PubMed ID: 12239155
[TBL] [Abstract][Full Text] [Related]
59. Gata2 deficiency delays leukemogenesis while contributing to aggressive leukemia phenotype in Cbfb-MYH11 knockin mice.
Saida S; Zhen T; Kim E; Yu K; Lopez G; McReynolds LJ; Liu PP
Leukemia; 2020 Mar; 34(3):759-770. PubMed ID: 31624376
[TBL] [Abstract][Full Text] [Related]
60. Prognostic of Core Binding Factor (CBF) Acute Myeloid Leukemia With Complex Karyotype.
Marcault C; Boissel N; Haferlach C; Loschi M; Raynaud S; Cluzeau T
Clin Lymphoma Myeloma Leuk; 2022 Mar; 22(3):e199-e205. PubMed ID: 34674982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
